JD Bioscience Inc. (JDB)
JD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. Our therapeutic area is mainly focused on metabolic diseases that lack medicine Our main therapeutic sectors are metabolic diseases, especially chronic liver disease, inflammatory bowel disease, heart diseases, acute pancreatitis, and cancer. Our goal is to provide safe and effective therapies We aim to develop first-in-class drugs for metabolic diseases that face a lack of medication, to provide a better life for patients and their families.
Find locations served, office locations
- Business Type:
- Industry Type:
- Market Focus:
- Internationally (various countries)
- Year Founded:
Letter from CEO
Before I started my own business, I thought my calling was to pass on my knowledge and expertise in chemistry to university students. However, after 20 years of experience as a researcher in the field of metabolic diseases, I realized that the quality of life of patients suffering from metabolic disorders had barely improved because effective drugs for disease as NASH or IBD had not yet been commercially available.
Once diagnosed with these diseases, patients cannot receive proper medical help because of a lack of medicines. Therefore, I decided to establish JD Bioscience to develop and provide potent medicines for patients suffering from metabolic diseases.
“Together we become stronger”
Even though JD Bioscience started as a small faculty startup at the Gwangju Institute of Science and Technology, we have strong collaborations with dedicated scientists from four renowned state-run research institutes in South Korea. Each member of the collaboration group contributes their expertise to develop first-in-class drug candidates that can improve the lives of patients with metabolic diseases.
Mission & Vison
To be the world’s top pharmaceutical company in the field of metabolic disease.
“To discover novel therapeutics for metabolic diseases with unmet medical needs to help people live longer and healthier”
Expanding the drug pipeline and making global licensing deals
- Surveying unmet medical needs
- Searching for novel biomarkers that meet unmet medical needs
- Initiating first-in-class drug development using novel biomarkers
- Making technology licensing deals
Initiating collaborative research with bio ventures
- Providing medicinal chemistry services to partners
- Accumulating knowledge and experience for novel drug development
- Creating a stable sales revenue
Developing drug candidates for metabolic diseases
- Inflammatory bowel disease
- Other diseases